Jiangxi Fushine Pharmaceutical Co Ltd (300497) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.31 Million ≈ $2.68 Million USD) by net assets (CN¥2.17 Billion ≈ $317.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Jiangxi Fushine Pharmaceutical Co Ltd (300497) market capitalisation for the company's overall valuation and market capitalisation.

Jiangxi Fushine Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Jiangxi Fushine Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangxi Fushine Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangxi Fushine Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Jiangxi Fushine Pharmaceutical Co Ltd (300497) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Douglas Emmett Inc NYSE:DEI	0.034x
Xiamen ITG Group Corp Ltd SHG:600755	0.080x
Offcn Education Technology Co Ltd SHE:002607	0.076x
Fine Organic Industries Limited NSE:FINEORG	0.066x
Gansu Qilianshan Cement Group Co Ltd SHG:600720	0.016x
Carabao Group Public Company Limited BK:CBG	0.036x
1st Source Corporation NASDAQ:SRCE	0.039x
Tecan Group AG SW:TECN	0.048x

Annual Cash Flow Conversion Efficiency for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. View 300497 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.20 Billion ≈ $321.96 Million	CN¥62.67 Million ≈ $9.17 Million	0.028x	-66.95%
2024-12-31	CN¥2.18 Billion ≈ $318.55 Million	CN¥187.64 Million ≈ $27.46 Million	0.086x	+428.84%
2023-12-31	CN¥2.47 Billion ≈ $361.55 Million	CN¥-64.76 Million ≈ $-9.48 Million	-0.026x	+41.66%
2022-12-31	CN¥2.69 Billion ≈ $393.58 Million	CN¥-120.85 Million ≈ $-17.68 Million	-0.045x	-280.87%
2021-12-31	CN¥2.91 Billion ≈ $426.02 Million	CN¥72.32 Million ≈ $10.58 Million	0.025x	-80.20%
2020-12-31	CN¥3.05 Billion ≈ $445.98 Million	CN¥382.35 Million ≈ $55.95 Million	0.125x	-43.29%
2019-12-31	CN¥1.53 Billion ≈ $223.52 Million	CN¥337.91 Million ≈ $49.45 Million	0.221x	+44.20%
2018-12-31	CN¥1.15 Billion ≈ $167.80 Million	CN¥175.91 Million ≈ $25.74 Million	0.153x	-29.62%
2017-12-31	CN¥966.71 Million ≈ $141.46 Million	CN¥210.72 Million ≈ $30.84 Million	0.218x	-9.34%
2016-12-31	CN¥784.17 Million ≈ $114.75 Million	CN¥188.53 Million ≈ $27.59 Million	0.240x	+93.69%
2015-12-31	CN¥596.21 Million ≈ $87.24 Million	CN¥74.01 Million ≈ $10.83 Million	0.124x	+12.02%
2014-12-31	CN¥283.26 Million ≈ $41.45 Million	CN¥31.39 Million ≈ $4.59 Million	0.111x	-55.50%
2013-12-31	CN¥229.76 Million ≈ $33.62 Million	CN¥57.22 Million ≈ $8.37 Million	0.249x	-27.25%
2012-12-31	CN¥184.60 Million ≈ $27.01 Million	CN¥63.20 Million ≈ $9.25 Million	0.342x	+22.08%
2011-12-31	CN¥120.52 Million ≈ $17.64 Million	CN¥33.80 Million ≈ $4.95 Million	0.280x	--

About Jiangxi Fushine Pharmaceutical Co Ltd

SHE:300497 China Biotechnology

Market Cap

$1.72 Billion

CN¥11.77 Billion CNY

Market Cap Rank

#6716 Global

#1368 in China

Share Price

CN¥21.86

Change (1 day)

-0.86%

52-Week Range

CN¥9.75 - CN¥23.34

All Time High

CN¥24.76